Risk factors for the early acquisition of human herpesvirus 6 and human herpesvirus 7 infections in children

Pediatric Infectious Disease Journal

Volumn 17, Issue 9, 1998, Pages 792-795

  Lanphear, Bruce P ^a,d   Hall, Caroline B ^b   Black, Jodi ^c   Auinger, Peggy ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Breast feeding; Children; Human herpesvirus; Human herpesvirus 6; Human herpesvirus 7; Infection; Risk factors

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

AGE; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; EXANTHEMA SUBITUM; FAMILY SIZE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; NEGRO; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SIBLING;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EXANTHEMA SUBITUM; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOBLOTTING; INFANT; LOGISTIC MODELS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 0031720254     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809000-00008     Document Type: Article

References (19)

1. Hall CB, Long CB, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med 1994;331:432-8.
2. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992;326:1445-50.
3. Levy AJ, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-50.
4. Huang LM, Lee CY, Chen JY, et al. Primary human herpesvirus 6 infection in children: a prospective serologic study. J Infect Dis 1992;165:1163-4.
5. Wyatt LS, Rodriguez WJ, Balachandran N, Frenkel N. Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol 1991;65:6260-5.
6. Yoshikawa T, Asano Y, Kobayashi I, et al. Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol 1993;41:319-23.
7. Clark DA, Freeland JML, Mackie PLK, Jarrett RF, Onions DE. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 1993;168:251-2.
8. Black JB, Schwarz TF, Patton JL, et al. Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diag Lab Immunol 1996;3:79-83.
9. Ablashi D, Agut H, Berneman Z, et al. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 1993;129:363-6.
10. Dewhurst S, Chandran B, Mcintyre K, Schnabel K, Hall CB. Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology 1992;190:490-3.
11. Dewhurst S, Mcintyre K, Schnabel K, Hall CB. Human herpesvirus-6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of US infants. J Clin Microbiol 1993;31:416-8.
12. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994;125:1-5.
13. Yasukawa M, Yakushijin Y, Furukawa M, Fujita S. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 1993;67:6259-64.
14. Torgoe S, Koide W, Yamada, ME, Tanaka-Taya K, Yamanishi K. Human herpesvirus 7 infection associated with central nervous suystem manifestations. J Pediatr 1996;129:301-5.
15. Caserta M, Hall CB, Schnabel K, D'Heron N. Human herpesvirus-7 (HHV-7) infection in US children [Abstract 996]. Presented at the American Pediatric Association Meeting, Washington, DC, May 2 to 5, 1996.
16. Foa-Tomasi L, Avitabile E, Ke L, Campadelli-Fiume G. Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6. J Gen Virol 1994;75:2719-27.
17. Torigoe S, Kumamoto T, Koide W, Taya K, Yamanishi K. Clinical manifestations associated with human herpesvirus 7 infection. Arch Dis Child 1995;72:518-9.
18. Berneman ZN, Ablashi DV, Li G, et al. Human herpes virus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 1992;89:10552-6.
19. Lanphear BP, Weitzman M, Winter NL, et al. Lead-contaminated house dust and urban children's blood lead levels. Am J Public Health 1996;86:1416-21.